Table 1.
Reference | n | Population | Tumour type | Biological fluid | Biomarker | Methods | Clinical application | Main findings of the study |
---|---|---|---|---|---|---|---|---|
Koch et al.37 | 11 | Adults | GBM | Plasma | MV count | Flow cytometry, Electron microscopy |
Response assessment | MV count helped to distinguish between tumour progression and pseudoprogression |
Shi et al.38 | 70 | n.r. | Grade 2 astrocytoma, Grade 2 ependymoma, GBM |
Plasma CSF |
miR-21 | TEM, WB, RT-PCR |
Prognosis | miR-21 levels can predict PFS and OS |
Evans et al.39 | 16 | Adults | GBM | Plasma | MV count | Flow cytometry, Cryoelectron microscopy |
Prognosis | MV count can predict PFS and OS |
Manda et al.46 | 96 | Adults | HGG | Serum | EGFRvIII | BCA protein assay, TEM, flow cytometry, RT-PCR | Prognosis | EGFRvIII expression in EVs correlates with OS |
Indira Chandran et al.44 | 82 | Adults | HGG and LGG | Plasma | SDC1 | NTA, TEM, ProSeek multiplex proximity extension assay, ELISA | Prognosis | SDC1 expression in EVs correlates with OS |
Osti et al.43 | 68 | Adults | GBM and other CNS tumours | Plasma | EVs count and size, proteomic profile | NTA, TEM, mass spectrometry | Response assessment | EVs can assist in GBM diagnosis and monitoring |
Zhong et al.40 | 147 | Adults | HGG | Serum | miR-29b | RT-PCR | Prognosis | miR-29b levels correlate with OS |
Batool et al.35 | 40 | Adults | HGG | Plasma | EGFRvIII | ddPCR | Response assessment | EGFRvIII mutant copies assisted in response assessment |
Khristov et al.41 | 82 | Adults | GBM | Plasma | IL13Ra2 | ELISA | Prognosis | IL13Ra2 levels in plasma correlate with OS |
Dobra et al.42 | 222 | Adults | GBM, meningiomas, brain metastases |
Serum | MMP-9 | NTA, TEM, WB, LC-MS, ELISA | Prognosis | MMP-9 levels correlate with OS |
ddPCR = digital droplet PCR; ELISA = enzyme-linked immunosorbent assay; EVs = extracellular vesicles; GBM = glioblastoma; HGG = high-grade gliomas; LC-MS = liquid chromatography–mass spectrometry; LGG = low grade gliomas; MV = microvesicles; n = number of patients included; n.r. = information not reported; NTA = nanoparticle tracking analysis; OS = overall survival; PFS = progression-free survival; RT-PCR = reverse transcription PCR; TEM = transmission electron microscopy; WB = western blot.